ijms-logo

Journal Browser

Journal Browser

Heart Failure: From Molecular Basis to Therapeutic Strategies

A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Pathology, Diagnostics, and Therapeutics".

Deadline for manuscript submissions: 30 August 2024 | Viewed by 361

Special Issue Editor


E-Mail Website
Guest Editor
Department of Medicine and Surgery, University of Salerno, 84081 Baronissi, Italy
Interests: molecular and clinical cardiology; new approaches for treatment of cardiovascular diseases
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

The molecular complexity of heart failure has dramatically increased since introducing the latest classification of preserved and reduced ejection fractions (HFpEF and HFrEF). Indeed, these two entities present different physiopathological mechanisms that are far from being elucidated. Understanding heart failure’s molecular mechanisms and providing deep phenotyping are crucial for developing novel and effective therapeutic strategies. In particular, HFpEF appears to be strictly related to cardiac metabolic remodeling and altered substrate utilization, leading to deficient energy production. This Special Issue aims to explore the molecular mechanisms involved in the pathogenesis of heart failure, evaluating the roles of various cellular and molecular players, including cardiomyocytes, fibroblasts, inflammatory mediators, and signaling cascades. Moreover, emerging therapeutic strategies, spanning from traditional pharmacological interventions to innovative gene- and cell-based therapies, will be considered.

Dr. Michele Ciccarelli
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • heart failure
  • cardiac metabolism
  • mitochondria
  • inflammatory pathway
  • neurohormonal system
  • therapeutical strategies

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Research

7 pages, 1639 KiB  
Communication
Epstein-Barr Virus Lytic Transcripts Correlate with the Degree of Myocardial Inflammation in Heart Failure Patients
by Christian Baumeier, Dominik Harms, Britta Altmann, Ganna Aleshcheva, Gordon Wiegleb, Thomas Bock, Felicitas Escher and Heinz-Peter Schultheiss
Int. J. Mol. Sci. 2024, 25(11), 5845; https://doi.org/10.3390/ijms25115845 - 28 May 2024
Viewed by 228
Abstract
The Epstein-Barr virus (EBV) is frequently found in endomyocardial biopsies (EMBs) from patients with heart failure, but the detection of EBV-specific DNA has not been associated with progressive hemodynamic deterioration. In this paper, we investigate the use of targeted next-generation sequencing (NGS) to [...] Read more.
The Epstein-Barr virus (EBV) is frequently found in endomyocardial biopsies (EMBs) from patients with heart failure, but the detection of EBV-specific DNA has not been associated with progressive hemodynamic deterioration. In this paper, we investigate the use of targeted next-generation sequencing (NGS) to detect EBV transcripts and their correlation with myocardial inflammation in EBV-positive patients with heart failure with reduced ejection fraction (HFrEF). Forty-four HFrEF patients with positive EBV DNA detection and varying degrees of myocardial inflammation were selected. EBV-specific transcripts from EMBs were enriched using a custom hybridization capture-based workflow and, subsequently, sequenced by NGS. The short-read sequencing revealed the presence of EBV-specific transcripts in 17 patients, of which 11 had only latent EBV genes and 6 presented with lytic transcription. The immunohistochemical staining for CD3+ T lymphocytes showed a significant increase in the degree of myocardial inflammation in the presence of EBV lytic transcripts, suggesting a possible influence on the clinical course. These results imply the important role of EBV lytic transcripts in the pathogenesis of inflammatory heart disease and emphasize the applicability of targeted NGS in EMB diagnostics as a basis for specific treatment. Full article
(This article belongs to the Special Issue Heart Failure: From Molecular Basis to Therapeutic Strategies)
Show Figures

Figure 1

Back to TopTop